SMAD4 and carcinoma: Previous studies have shown that loss of SMAD4 is found in 30–40% colorectal cancer patients [1], which occurs late in adenoma-to-carcinoma sequence [16], leading to liver metastases, and these patients have a poor response to chemotherapy following with poor prognosis [17].